Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

(2015) Hui Gao et al.   NATURE MEDICINE

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

(2015) Zachary C. Dobbin et al.   Oncotarget

miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma

(2015) Ruifen Dong et al.   Oncotarget

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma

(2014) Qing Zhang et al.   CANCER

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

(2014) F. Ricci et al.   CANCER RESEARCH

Tumorgrafts asIn VivoSurrogates for Women with Ovarian Cancer

(2014) S. John Weroha et al.   CLINICAL CANCER RESEARCH

Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

(2014) Jeong-Won Lee et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: An In Vivo Study in Orthotopic Xenografts of Nude Mice

(2014) X. Xu et al.   MOLECULAR CANCER THERAPEUTICS

Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts

(2014) Monique D. Topp et al.   Molecular Oncology

Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy

(2014) Suping Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

(2014) M. Hidalgo et al.   Cancer Discovery

Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

(2014) Jolijn W. Groeneweg et al.   Frontiers in Oncology

One mouse, one patient paradigm: New avatars of personalized cancer therapy

(2013) Prerna Malaney et al.   CANCER LETTERS

Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models

(2013) D. Siolas et al.   CANCER RESEARCH

Through the glass darkly: intraepithelial neoplasia, top-down differentiation, and the road to ovarian cancer

(2013) Christopher P Crum et al.   JOURNAL OF PATHOLOGY

Patient-Derived Xenograft Models to Improve Targeted Therapy in Epithelial Ovarian Cancer Treatment

(2013) Clare L. Scott et al.   Frontiers in Oncology

Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer

(2012) A. Vidal et al.   CLINICAL CANCER RESEARCH

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

(2011) Michael P. Stany et al.   PLoS One

Humanized Mouse Model of Ovarian Cancer Recapitulates Patient Solid Tumor Progression, Ascites Formation, and Metastasis

(2011) Richard B. Bankert et al.   PLoS One

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model

(2011) Christopher K. McCann et al.   PLoS One

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

(2011) J. M. Stewart et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts

(2010) U. Kortmann et al.   CLINICAL CANCER RESEARCH

Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients

(2008) B Rubio-Viqueira et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy

(2008) Joshua Z. Press et al.   GYNECOLOGIC ONCOLOGY